NovaBay Pharmaceuticals (NYSE:NBY) said today that its shareholders have approved a deal to issue 2.4 million shares of common stock as part of a $10.3 million deal with Beijing-based Ch-gemstone Capital.
The private placement is slated to close in January next year, contingent upon approval by regulatory authorities in China.
Get the full story at our sister site, Drug Delivery Business News.
The post NovaBay shareholders clear $10m stock deal appeared first on MassDevice.